- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- Antiviral Drug Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)
Antiviral drugs are the ones used for treating viral infections rather than bacterial ones. Antiviral drugs are of antimicrobials which include antibiotic or antiviral drugs based on monoclonal antibodies. The market is estimated to be USD 45.64 Billion by 2024 from USD 32.48 Billion in 2017 at a CAGR of 5.78%.
Global antiviral drug market share:
North America is expected to have the most significant percentage and that is due to the presence of ample opportunities for pharmaceutical companies to market the product and rise in viral infection incidences and increase in public awareness.
Global antiviral drug market size:
Technology, end user and type segment the antiviral drug market. The technology is having the most significant demand as these drugs are used for viral infections such as HIV, herpes, hepatitis and influenza while most of these are used for specific viral infections and few for broad-range of areas.
Global antiviral drug market growth:
The growth of antiviral drug market is majorly driven by an increase in public awareness, rise in healthcare expenditure, R & D development incidence of virus life-threatening diseases and rate of growth of viral infections like HIV herpes and hepatitis.
Global antiviral drug market industry analysis:
The market is classified as technology, end user and type. The technology is segmented into HIV, Hepatitis, herpes and influenza. Type is classified into branded and genetics. Here the primary market is based on the viral infections that are HIV and others.
Global antiviral drug market outlook:
Global antiviral drug market majorly deals with the medication for viral infections. Most antivirals are used for specific viral infections while a broad spectrum antiviral is effective against wide range of viruses. Most of the firms and industries are trying to develop the technologies and monitor the viral infections. The growth is predominant in North America.
Global antiviral drug market Trends:
Johnson & Johnson was offering the world’s most extensive range of consumer healthcare products.Cipla is the world’s largest manufacturer of antiviral drugs and has the products pharmaceutical ingredients to other manufacturers as well as pharmaceuticals and personal care products.
Global antiviral drug market Research reports:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Massachusetts Institute
- Abbott Healthcare
- Johnson and Johnson
- Roche Holding Ag
- Cipla
- Merck & Co
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 HIV/AIDS therapeutics market
6.3 Hepatitis therapeutics
6.3.1 Hepatitis B
6.3.2 Hepatitis C
6.4 Herpes therapeutics
6.5 Influenza antivirals
6.6 Others
Chapter 7 Market Segmentation by the end user
7.1 Introduction
7.2 Hospitals
7.3 Clinics
7.4 Ambulatory surgical centres
7.5 Others
Chapter 8 Market Segmentation by Type
8.1 Introduction
8.2 Branded
8.3 Genetics
8.4 Others
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.1 USA
9.1.2 Canada
9.1.3 Mexico
9.1.4 Others
9.2 Europe
9.2.1 Introduction
9.2.2 UK
9.2.3 France
9.2.4 Germany
9.2.5 Italy
9.2.6 Spain
9.2.7 Others
9.3 Asia-Pacific
9.3.1 Introduction
9.3.2 Japan
9.3.3 China
9.3.4 India
9.3.5 Australia
9.3.6 South Korea
9.3.7 Others
9.4 South America
9.4.1 Introduction
9.4.2 Brazil
9.4.3 Argentina
9.4.4 Others
9.5 The Middle-East and Africa
9.5.1 Introduction
9.5.2 South Africa
9.5.3 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Abbott Healthcare
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Johnson and Johnson
11.3 Roche Holding Ag
11.4 Cipla
11.5 Merck & Co
11.6 Gilead
11.7 Schering-Plough
11.8 GlaxoSmithKline
11.9 AstraZeneca
11.10 Bristol-Myers-Squibb
11.11 Schering-Plough
11.12 ImmuneMed
11.13 DR Reddy
Chapter 12 Market Estimates and Forecast
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecast by Type 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecast by end user 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
13.1.5 Market Estimates and forecast by company Profiles 2018-2024(USD million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,489.86 - €7,469.57
- INR: ₹225,053.86 - ₹675,161.59
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.43 - £6,400.30
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Antiviral drugs are the ones used for treating viral infections rather than bacterial ones. Antiviral drugs are of antimicrobials which include antibiotic or antiviral drugs based on monoclonal antibodies. The market is estimated to be USD 45.64 Billion by 2024 from USD 32.48 Billion in 2017 at a CAGR of 5.78%.
Global antiviral drug market share:
North America is expected to have the most significant percentage and that is due to the presence of ample opportunities for pharmaceutical companies to market the product and rise in viral infection incidences and increase in public awareness.
Global antiviral drug market size:
Technology, end user and type segment the antiviral drug market. The technology is having the most significant demand as these drugs are used for viral infections such as HIV, herpes, hepatitis and influenza while most of these are used for specific viral infections and few for broad-range of areas.
Global antiviral drug market growth:
The growth of antiviral drug market is majorly driven by an increase in public awareness, rise in healthcare expenditure, R & D development incidence of virus life-threatening diseases and rate of growth of viral infections like HIV herpes and hepatitis.
Global antiviral drug market industry analysis:
The market is classified as technology, end user and type. The technology is segmented into HIV, Hepatitis, herpes and influenza. Type is classified into branded and genetics. Here the primary market is based on the viral infections that are HIV and others.
Global antiviral drug market outlook:
Global antiviral drug market majorly deals with the medication for viral infections. Most antivirals are used for specific viral infections while a broad spectrum antiviral is effective against wide range of viruses. Most of the firms and industries are trying to develop the technologies and monitor the viral infections. The growth is predominant in North America.
Global antiviral drug market Trends:
Johnson & Johnson was offering the world’s most extensive range of consumer healthcare products.Cipla is the world’s largest manufacturer of antiviral drugs and has the products pharmaceutical ingredients to other manufacturers as well as pharmaceuticals and personal care products.
Global antiviral drug market Research reports:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Massachusetts Institute
- Abbott Healthcare
- Johnson and Johnson
- Roche Holding Ag
- Cipla
- Merck & Co
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 HIV/AIDS therapeutics market
6.3 Hepatitis therapeutics
6.3.1 Hepatitis B
6.3.2 Hepatitis C
6.4 Herpes therapeutics
6.5 Influenza antivirals
6.6 Others
Chapter 7 Market Segmentation by the end user
7.1 Introduction
7.2 Hospitals
7.3 Clinics
7.4 Ambulatory surgical centres
7.5 Others
Chapter 8 Market Segmentation by Type
8.1 Introduction
8.2 Branded
8.3 Genetics
8.4 Others
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.1 USA
9.1.2 Canada
9.1.3 Mexico
9.1.4 Others
9.2 Europe
9.2.1 Introduction
9.2.2 UK
9.2.3 France
9.2.4 Germany
9.2.5 Italy
9.2.6 Spain
9.2.7 Others
9.3 Asia-Pacific
9.3.1 Introduction
9.3.2 Japan
9.3.3 China
9.3.4 India
9.3.5 Australia
9.3.6 South Korea
9.3.7 Others
9.4 South America
9.4.1 Introduction
9.4.2 Brazil
9.4.3 Argentina
9.4.4 Others
9.5 The Middle-East and Africa
9.5.1 Introduction
9.5.2 South Africa
9.5.3 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Abbott Healthcare
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Johnson and Johnson
11.3 Roche Holding Ag
11.4 Cipla
11.5 Merck & Co
11.6 Gilead
11.7 Schering-Plough
11.8 GlaxoSmithKline
11.9 AstraZeneca
11.10 Bristol-Myers-Squibb
11.11 Schering-Plough
11.12 ImmuneMed
11.13 DR Reddy
Chapter 12 Market Estimates and Forecast
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecast by Type 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecast by end user 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
13.1.5 Market Estimates and forecast by company Profiles 2018-2024(USD million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.